Group 1 - Morgan Stanley's trading department has noted an increase in attention and trading activity in the Chinese dairy industry, influenced by government policies on infant formula and the industry's strong domestic characteristics [1] - Despite the anticipated poor performance in 2024, Yili's (600887.SH) 2025 performance guidance is reassuring, with sales, reported earnings, and recurring earnings expected to grow by 3.4%, 34%, and 80% year-on-year respectively [1] - The new target price for Yili is set at 35 RMB, up from 30 RMB, with an expected price-to-earnings ratio of 18 times for 2026, reaffirming it as the preferred stock in the Chinese dairy sector [1] Group 2 - Yili anticipates a reversal of the surplus in raw milk supply in the second half of 2025 due to reduced dairy farm capacity, rising beef prices accelerating farm closures, and ongoing trade wars pushing up feed costs [2] - This situation is viewed positively for the entire industry, leading to upgraded ratings for Mengniu (02319) and Feihe (06186) [2]